US 12252481
Anti-viral compounds
granted A61KA61K31/4025A61K31/404
Quick answer
US patent 12252481 (Anti-viral compounds) held by Aligos Therapeutics, Inc. expires Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aligos Therapeutics, Inc.
- Grant date
- Tue Mar 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K31/4025, A61K31/404, A61K31/4155, A61K31/4192